RxDoctor Payments Data

Elena Burtea, MD

Family Medicine · Carmel, INNPI 1376626663

Payments from drug & device makers

$2,424in general payments, 2019–2025

Across 155 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$512
  • Novo Nordisk$381
  • Lilly USA, LLC$313
  • Amgen$198
  • Pfizer$157
  • GSK$134
  • plus $730 from 18 others

What the payments were for

  • Food & beverage$2,424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,424 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$26,238
Medicare patients
87
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$34,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$34,128
TrulicityDulaglutide14$26,936
JardianceEmpagliflozin14$23,623
EliquisApixaban21$20,593
MyrbetriqMirabegron13$14,653
TrintellixVortioxetine Hydrobromide17$12,718
RybelsusSemaglutide11$9,047
Jentadueto XrLinagliptin/Metformin Hcl20$5,922
Rosuvastatin Calcium198$2,184
Estradiol30$1,970
Tolterodine Tartrate ErTolterodine Tartrate11$1,588
Nebivolol Hcl23$1,055
SynthroidLevothyroxine Sodium19$974
Raloxifene Hcl32$896

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$381$43,73533 claims
GSKTrelegy Ellipta$134$34,12831 claims
Lilly USA, LLCTrulicity$313$26,93614 claims
PfizerEliquis$157$20,59321 claims
Astellas Pharma US IncMyrbetriq$74$14,65313 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$131$12,71817 claims
AbbVieSynthroid$512$97419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →